CARVER, Massachusetts December 11, 2006 – Decas Botanical Synergies (DBS), a subsidiary of Decas Cranberry Products, Inc., asserts the unique status of its cranberry supplement, PACran, as the first cranberry supplement which is both clinically supported at a dose of 500 mg per day and standardized to 1.5% of proanthocyanidins (PACs) measured via the only published and USDA-recognized HPLC methodology.
The company also asserts that neither PACran nor DBS’s method of producing it infringes a competitor’s patent, as has been alleged. PACran is made exclusively from whole high-PAC Early Black cranberries using a proprietary manufacturing process entirely different from that described in the competitor’s patent. The unique process used in manufacturing PACran permits better standardization of PACs, the active compound that promotes urinary tract health. Early Black cranberries have been found to have higher levels of PACs than other types of cranberries. PACran’s manufacturing processes help to retain these high levels.
“We have seen tremendous interest in PACran since we announced the results of our clinical trial,“ said Doug Klaiber, DBS general manager. “The market has been looking for a cranberry supplement that guarantees standard amounts of the active compound and has clinical proof. What clearly distinguishes PACran from our competition is that we can guarantee the amount of the active compound that was successful in our clinical trial. Additionally, we have comparative laboratory tests verifying that PACran contains significantly more PACs than other products purchased from retail stores.”
DBS has set a new standard with PACran in response to consumer demand for the proper amount of active cranberry compounds to promote urinary tract health, and for validation of the product’s effectiveness in clinical trials.
Learn more about PACran and the importance of proanthocyanidins (PACs) on the newly launched web site http://www.PACran.com.
About Decas Botanical Synergies (DBS)
Headquartered in Carver, Massachusetts, Decas Botanical Synergies (DBS), a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of proprietary, value-added fruit-derived ingredients for the dietary supplement, functional foods, animal feed and nutrition, personal care and cosmetics, and oral health industries. Specializing in cranberries, DBS’ FruitaceuticalÔ products are rich in natural bioflavonoid complexes, which provide manufacturers with powerful antioxidant, antimicrobial and nutritional properties, and a natural colorant for a broad variety of applications. Decas powders, extracts and oils offer cost-effective and natural options to enhance the taste, color, function and nutritional content of products. For additional information, please visit www.decasbotanical.com.
For additional information, please contact:
Decas Botanical Synergies